Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenQuadfi vs Nimenrix or NeisVac-C in Toddlers
NCT03890367Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2019
- Primary completion
- Oct 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of meningococcal A conjugate vaccine in invasive meningococcal disease (IMD), sponsored by Sanofi. Started Sep 2019; status: completed.
02
Drugs
meningococcal A conjugate vaccine
03
Conditions
invasive meningococcal disease (IMD)
Beyond the preview
Go deeper on NCT03890367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03890367.